Abstract:
Patients with coronary heart disease (CHD) are at high cardiovascular risk (CVR), due to a complex set of inter-related hemodynamic, metabolic and neurohormonal disorders. Particular importance is the correction of body weight as one of the most modifiable risk factors.The connecting link between the risk of coronary heart disease and obesity is dyslipidemia. The use of pharmaceutical products
helps to improve the results of treatment of CHD, however, drug therapy has a number of disadvantages, the main of which are allergic reactions, development of addiction, side effects. Rehabilitation treatment of patients with CHD in the sanatorium stage provides for the mandatory inclusion of non-drug interventions, such as: physical therapy and dietetics. One of the promising directions of currently
researchof correction of weight is the use of functional foods. We have received positive results in preliminary studies in athletes by use of functional foods containing L-carnitine.On this basis, we have developed functional product for patients with CHD taking into account peculiarities of metabolism.
